LOADING
Comparing Merck & Company (MRK) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CRM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | -- |
| P/E Ratio | 116.4 | -- |
| Forward P/E | 15.3 | -- |
| PEG Ratio | 2.71 | -- |
| EPS | $1.24 | -- |
| Revenue Growth (YoY) | 5.1% | -- |
| Profit Margin | 4.8% | -- |
| Return on Equity | 7.0% | -- |
| Dividend Yield | 2.31% | -- |
| Beta | 0.23 | -- |
| 52-Week High | $156.00 | -- |
| 52-Week Low | $79.67 | -- |
| Volume | -- | -- |